Page 3 - Maggie Fick Editing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Maggie fick editing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Maggie Fick Editing Today - Breaking & Trending Today

UK probing Novo's Ozempic, weight-loss drug Saxenda over suicidal, self-harming thoughts

Britain is reviewing a class
of drugs used in a diabetes medicine and a weight-loss treatment
sold by Novo Nordisk after some patients reported
suicidal or self-harming thoughts, two weeks after. ....

United States , United Kingdom , City Of , Novo Ozempic , Eli Lilly , Mark Potter , Novo Saxenda , Josephine Mason , European Medicines Agency , Regulatory Agency , Novo Nordisk , European Union , Yellow Card , Maggie Fick Editing ,

Exclusive: UK probing Novo's Ozempic, weight-loss drug Saxenda over suicidal, self-harming thoughts

Exclusive: UK probing Novo's Ozempic, weight-loss drug Saxenda over suicidal, self-harming thoughts
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , United States , Mark Potter , Josephine Mason , Novo Saxenda , Novo Ozempic , Thomson Reuters Trust Principles , European Union , Regulatory Agency , Novo Nordisk Novob , European Medicines Agency , Novo Nordisk , Eli Lilly , Yellow Card , Maggie Fick Editing , Thomson Reuters Trust ,

Novo Nordisk says Wegovy launch in Germany won't hit U.S. supplies

Novo Nordisk will
launch its weight-loss drug Wegovy in Germany this month with
the injection pen used in Norway and Denmark, instead of the one
deployed in the United States to avoid hitting supplies. ....

United States , City Of , United Kingdom , Mark Potter , Michael Leuchten , Josephine Mason , Novo Nordisk , Maggie Fick Editing ,

AstraZeneca beats estimates on strong emerging market sales as COVID wanes

AstraZeneca on Thursday beat expectations for first-quarter profit and revenue, as buoyant sales of cancer drug Imfinzi and strong demand for its roster of drugs in emerging markets helped to offset dwindling COVID product sales. ....

City Of , United Kingdom , Natalie Grover , Pascal Soriot , Tomasz Janowski , Thomson Reuters Trust Principles , Maggie Fick Editing , Thomson Reuters Trust , Rhpi Commercial Strategy , Rhpi Government Health Policy , Rhpi Public Health ,

GSK sees $500 mln peak sales for yeast infection pill licensed from Scynexis

LONDON British drugmaker GSK sees peak sales of more than $500 million for a drug to treat yeast infections that it licensed from U.S. biotech company… ....

United Kingdom , New York , United States , City Of , Mark Potter , Luke Miels , Maggie Fick , National Post , Postmedia Network Inc , Drug Administration , Postmedia Network , Street East , Commercial Officer Luke Miels , New York Times , Disease Control , Maggie Fick Editing ,